1. Home
  2. TLF vs JSPR Comparison

TLF vs JSPR Comparison

Compare TLF & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

N/A

Current Price

$2.33

Market Cap

18.2M

ML Signal

N/A

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.49

Market Cap

14.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLF
JSPR
Founded
1980
2018
Country
United States
United States
Employees
N/A
22
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
14.9M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
TLF
JSPR
Price
$2.33
$0.49
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$15.50
AVG Volume (30 Days)
39.4K
657.7K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
32.05%
N/A
EPS Growth
1122.22
N/A
EPS
0.03
N/A
Revenue
$76,324,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$78.33
N/A
Revenue Growth
2.60
N/A
52 Week Low
$2.20
$0.42
52 Week High
$3.78
$7.19

Technical Indicators

Market Signals
Indicator
TLF
JSPR
Relative Strength Index (RSI) 47.91 33.53
Support Level $2.25 $0.42
Resistance Level $2.45 $1.02
Average True Range (ATR) 0.07 0.07
MACD 0.00 0.00
Stochastic Oscillator 32.35 30.39

Price Performance

Historical Comparison
TLF
JSPR

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: